Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05544903 · ClinicalTrials.gov registry record
Point of Care Ultrasound to Predict Intensive Care Unit Admission of Patients Presenting With Sepsis to the Emergency Department
A clinical trial, sponsored by Northwell Health.
- Completed
- Registry status
- 134
- Enrollment target
NCT05544903 is a clinical trial that has completed, run by Northwell Health. The registered enrollment target is 134 participants.
The verdict
NCT05544903 has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- 134 participants
- Enrollment target
Study Summary
The FloPatch device will be applied to 150 septic patients in the emergency department before they receive fluid resuscitation. This study will assess whether initial FloPatch measured volume-responsiveness and volume of fluids used will predict a composite outcome of mortality, intensive care unit admission, or rapid response team activation. The development of fluid unresponsiveness throughout the initial fluid resuscitation will be assessed and its association with the composite outcome will be assessed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2023-12-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05544903
The ClinicalTrials.gov registry entry for NCT05544903 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05544903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05544903 about?
NCT05544903 is a clinical study titled "Point of Care Ultrasound to Predict Intensive Care Unit Admission of Patients Presenting With Sepsis to the Emergency Department". The FloPatch device will be applied to 150 septic patients in the emergency department before they receive fluid resuscitation. This study will assess whether initial FloPatch measured volume-responsiveness and volume of fluids used will predict a composite outcome of mortality, intensive care unit ...
What is the current status of trial NCT05544903?
This trial is currently completed. The enrollment target is 134 participants. The study started on 2022-09-01. Estimated completion is 2023-12-18.
Who is sponsoring clinical trial NCT05544903?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.